Safe Supply Streaming Co Ltd. and MDBio Sign U.S. Manufacturing Agreement for ToxiShield Products Amidst Record Federal Overdose Crisis Funding
Safe Supply Streaming (OTCQB:SSPLF) has signed a 12-month manufacturing agreement with MDBio to produce 200,000 ToxiShield products in the United States. The agreement, focused on domestic production at MDBio's Sugar Land, Texas facility, comes shortly after the U.S. Department of Health and Human Services allocated $1.5 billion in funding for State and Tribal Opioid Response programs.
ToxiShield, developed by Safe Supply's subsidiary Safety Strips Tech Corp., provides rapid test kits for detecting fentanyl and other harmful substances. Each unit contains five test kits with buffer solution, sampling tools, and QR-linked instructions. The manufacturing partnership aims to support communities, universities, nonprofits, and public agencies utilizing SOR and TOR grants for overdose prevention initiatives.
Safe Supply Streaming (OTCQB:SSPLF) ha stipulato un accordo di produzione della durata di 12 mesi con MDBio per realizzare 200.000 prodotti ToxiShield negli Stati Uniti. L'accordo, mirato alla produzione domestica nello stabilimento di MDBio a Sugar Land, in Texas, arriva poco dopo che il Dipartimento della Salute e dei Servizi Umani degli Stati Uniti ha destinato 1,5 miliardi di dollari ai programmi di Risposta agli Oppioidi Statali e Tribali.
Il ToxiShield, sviluppato dalla controllata Safety Strips Tech Corp., offre kit di test rapidi per rilevare fentanyl e altre sostanze dannose. Ogni unità contiene cinque kit di test con soluzione tampone, strumenti di campionamento e istruzioni collegate a un QR. La partnership di produzione mira a sostenere comunità, università, organizzazioni non profit e enti pubblici che utilizzano sovvenzioni SOR e TOR per iniziative di prevenzione delle overdose.
Safe Supply Streaming (OTCQB:SSPLF) ha firmado un acuerdo de fabricación de 12 meses con MDBio para producir 200.000 productos ToxiShield en Estados Unidos. El acuerdo se centra en la producción nacional en la instalación de MDBio en Sugar Land, Texas, y llega poco después de que el Departamento de Salud y Servicios Humanos de EE. UU. asignara 1,5 mil millones de dólares a los programas de Respuesta a Opioides Estatales y Tribales.
El ToxiShield, desarrollado por la filial Safety Strips Tech Corp., ofrece kits de pruebas rápidas para detectar fentanilo y otras sustancias nocivas. Cada unidad contiene cinco kits de prueba con solución tampón, herramientas de muestreo e instrucciones vinculadas a un código QR. La asociación de fabricación tiene como objetivo apoyar a comunidades, universidades, organizaciones sin fines de lucro y agencias públicas que utilizan las subvenciones SOR y TOR para iniciativas de prevención de sobredosis.
Safe Supply Streaming (OTCQB:SSPLF)가 MDBio와 12개월 제조 계약을 체결하여 미국에서 200,000개의 ToxiShield 제품을 생산합니다. 이번 계약은 MDBio의 텍사스주Sugar Land 시설에서의 국내 생산에 초점을 두고 있으며, 미국 보건복지부가 주 및 부족 오피오이드 대응 프로그램에 15억 달러를 배정한 직후에 체결되었습니다.
ToxiShield는 Safe Supply의 자회사인 Safety Strips Tech Corp.가 개발했으며 펜타닐 및 기타 해로운 물질을 빠르게 탐지하는 테스트 키트를 제공합니다. 각 유닛은 버퍼 용액, 샘플링 도구, QR로 연결된 지침이 담긴 다섯 개의 테스트 키트를 포함합니다. 제조 파트너십은 SOR 및 TOR 보조금을 활용하는 커뮤니티, 대학, 비영리단체 및 공공 기관의 Overdose 예방 이니셔티브를 지원하는 것을 목표로 합니다.
Safe Supply Streaming (OTCQB:SSPLF) a signé un accord de fabrication de 12 mois avec MDBio pour produire 200 000 produits ToxiShield aux États-Unis. L'accord se concentre sur la production nationale dans l facilities de MDBio à Sugar Land, Texas, et intervient peu après que le Department of Health and Human Services des États-Unis a alloué 1,5 milliard de dollars aux programmes de Réponse aux opioïdes étatiques et tribaux.
Le ToxiShield, développé par la filiale Safety Strips Tech Corp., fournit des kits de test rapides pour détecter le fentanyl et d'autres substances nocives. Chaque unité contient cinq kits de test avec une solution tampon, des outils d'échantillonnage et des instructions liées à un QR. Le partenariat de fabrication vise à soutenir les communautés, les universités, les organisations à but non lucratif et les agences publiques qui utilisent les subventions SOR et TOR pour des initiatives de prévention des overdoses.
Safe Supply Streaming (OTCQB:SSPLF) hat eine 12-monatige Fertigungsvereinbarung mit MDBio getroffen, um 200.000 ToxiShield-Produkte in den USA herzustellen. Die Vereinbarung konzentriert sich auf die inländische Produktion in MDBios Einrichtung in Sugar Land, Texas, und erfolgt kurz nachdem das US-Gesundheits- und Sozialministerium 1,5 Milliarden US-Dollar für State- und Tribal-Opioid-Response-Programme bereitgestellt hat.
ToxiShield, entwickelt von Safe Supplys Tochtergesellschaft Safety Strips Tech Corp., bietet Schnelltests zum Nachweis von Fentanyl und anderen schädlichen Substanzen. Jede Einheit enthält fünf Testkits mit Pufferlösung, Abnahmewerkzeugen und QR-verknüpften Anweisungen. Die Fertigungspartnerschaft zielt darauf ab, Gemeinschaften, Universitäten, gemeinnützige Organisationen und öffentliche Behörden zu unterstützen, die SOR- und TOR-Zuschüsse für Präventionsinitiativen gegen Überdosen nutzen.
Safe Supply Streaming (OTCQB:SSPLF) وقّعت اتفاقية تصنيع لمدة 12 شهراً مع MDBio لإنتاج 200,000 منتج ToxiShield في الولايات المتحدة. تتركز الاتفاقية على الإنتاج المحلي في مرفق MDBio في Sugar Land بولاية تكساس، وتأتي بعد أن خصص وزارة الصحة والخدمات البشرية الأمريكية 1.5 مليار دولار لبرامج الاستجابة للأفيونيات على المستويين الولائي والقبلي.
يُطوِّر ToxiShield شركة Safety Strips Tech Corp. الفرعية لـ Safe Supply، وهو يوفر أطقم اختبارات سريعة لاكتشاف الفنتانيل وغيرها من المواد الضارة. تحتوي كل وحدة على خمسة أطقم اختبار مع محلول عازل وأدوات أخذ العينات وأدلة مرتبطة برمز QR. يهدف شراكة التصنيع إلى دعم المجتمعات والجامعات والمنظمات غير الربحية والجهات العامة التي تستخدم منح SOR و TOR لمبادرات الوقاية من تعاطي المواد الزائدة.
Safe Supply Streaming (OTCQB:SSPLF) 已与 MDBio 签订为期 12 个月的制造协议，在美国生产 200,000 份 ToxiShield 产品。该协议专注于在 MDBio 位于德州 Sugar Land 的设施进行国内生产，正值美国卫生与公众服务部为州级和部落阿片类药物应对计划拨款 15 亿美元之后。
ToxiShield 由 Safe Supply 的子公司 Safety Strips Tech Corp. 开发，提供用于快速检测芬太尼及其他有害物质的试剂盒。每个单元包含五份带缓冲液的试剂盒、采样工具及与二维码相连的说明。制造伙伴关系旨在支持 wykorzyst SOR 与 TOR 资助、从事阿片类药物过量预防计划的社区、大学、非营利组织及公共机构。
- Strategic manufacturing agreement secured for 200,000 ToxiShield units production
- Domestic U.S. manufacturing enables faster response to market demands
- Timing aligns with $1.5B government funding allocation for opioid response
- Product positioned to capture share of large-scale federal health initiatives
- Limited 12-month term for the manufacturing agreement
- Production capacity confined to 200,000 units initially
Toronto, Ontario--(Newsfile Corp. - September 30, 2025) - Safe Supply Streaming Co Ltd. (CSE: SPLY) (OTCQB: SSPLF) (FSE: QM4) ("Safe Supply" or the "Company") today announced it has entered into a 12-month manufacturing and supply agreement with MobileDetect Bio, Inc. ("MDBio") to support the U.S. production and distribution of 200,000 custom ToxiShield products, developed by Safe Supply's wholly owned subsidiary, Safety Strips Tech Corp. ("Safety Strips")
This milestone comes a week after the U.S. Department of Health and Human Services (HHS) allocated more than
"This agreement provides a critical foundation for scaling our public health response in the U.S.," said Geoff Benic, CEO of Safe Supply and Co-Chair of the Make America Healthy Again (MAHA) Coalition. "By manufacturing domestically with MDBio, we're able to respond quickly and reliably to the needs of communities, universities, nonprofits, and public agencies already mobilizing under SOR and TOR grants."
ToxiShield is the trusted brand behind Safety Strips, providing discreet, rapid test kits used to detect fentanyl, drink-spiking, and other harmful substances to empower individuals and communities to take health and safety into their own hands. The agreement enables bulk production of the units, with each containing five test kits, at MDBio's facility in Sugar Land, Texas. All kits ship with pre-measured buffer solution, sampling tools, and QR-linked usage instructions to support high-fidelity deployment in the field.
"This initiative reflects the Company's broader mission to meet urgent public health needs with scalable, science-based technologies," said Raf Souccar, Chairman of the Board of Safe Supply and former Deputy Commissioner of the Royal Canadian Mounted Police (RCMP). "As someone who has worked on the front lines of the opioid crisis, I see firsthand the value of tools that empower communities to intervene early and save lives."
Aligning with National Priorities and Public Funding
The announcement coincides with HHS's September 22nd commitment of
The collaboration between Safe Supply and MDBio directly supports these goals through Made-in-America innovation, and is fully aligned with MAHA's mission to deliver practical, evidence-informed solutions to communities nationwide.
About Safety Strips Tech Corp.
Safety Strips Tech Corp., a wholly owned subsidiary of Safe Supply Streaming Co Ltd., develops and commercializes innovative health and safety tools, including proprietary fentanyl detection kits and drink spike test kits, providing individuals and communities with critical protections in a discreet, affordable format.
About Safe Supply Streaming Co Ltd.
Safe Supply Streaming Co Ltd. (CSE: SPLY) (FSE: QM4) (OTCQB: SSPLF) is a publicly traded company focused on advancing innovation in healthcare, wellness, and emerging technologies. Through strategic acquisitions, partnerships, and capital investments, Safe Supply is building a diversified portfolio of companies that leverage data, science, and digital platforms to improve outcomes, drive accessibility, and scale impact. Operating at the intersection of public health and technology, Safe Supply supports evidence-informed solutions to urgent societal needs. Its wholly owned subsidiaries, including Safety Strips Tech Corp. and Drug Lab 118 Ltd., develop proprietary rapid testing technologies such as fentanyl and drink-spiking detection products which are designed to improve health outcomes and enhance public wellness.
About MobileDetect Bio, Inc.
MobileDetect Bio, Inc. is a U.S.-based health innovation company that manufactures and supplies harm-reduction drug-checking products-including fentanyl, xylazine, nitazene, and medetomidine test strips-along with configurable, all-inclusive kits. Programs can tailor kit counts and add custom branding, labels, and QR links; kits ship with pre-measured buffer solution, swabs, and QR-coded instructions for fast, consistent use. MDBio also provides training resources and bulk/non-profit pricing to help community organizations deploy testing at scale.
For more information, please visit www.safesupply.com.
On behalf of the Board of Directors of Safe Supply Streaming Co Ltd.
"Geoff Benic"
Geoff Benic, CEO
Media & Investor Contact:
Safe Supply Streaming Co Ltd.
Email: info@safesupply.com
Geoff Benic, Chief Executive Officer
Email: geoff@safesupply.com
Phone: +1 647-880-7314
Website: www.safesupply.com
The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this news release and has neither approved nor disapproved its contents.
Cautionary Note and Forward-Looking Statements
This press release contains "forward-looking information" and "forward-looking statements" (collectively, "forward-looking statements") within the meaning of applicable Canadian and U.S. securities laws, including the United States Private Securities Litigation Reform Act of 1995. All statements, other than statements of historical fact, are forward-looking statements and are based on expectations, estimates, and projections as at the date of this release. Forward-looking statements in this press release include, but are not limited to, statements with respect to: the anticipated benefits and impact of the manufacturing and supply agreement with MobileDetect Bio, Inc.; the scale, production volume, and deployment of ToxiShield products; the alignment of such products with public health priorities and federal funding initiatives; the Company's growth strategy and business objectives; and the expected performance and expansion of its subsidiaries.
Forward-looking statements are inherently subject to risks and uncertainties that may cause actual results, performance, or achievements to differ materially from those expressed or implied by such forward-looking statements. These risks and uncertainties include, without limitation, operational risks; regulatory and governmental approvals and compliance; market demand and acceptance of the Company's products; economic and competitive conditions; reliance on third-party manufacturing and logistics; supply chain constraints; fluctuations in operating results; and other factors described in the Company's public filings available under its profile on SEDAR+ at www.sedarplus.ca.
Readers are cautioned not to place undue reliance on forward-looking statements. The Company does not undertake any obligation to update or revise any forward-looking statement, whether as a result of new information, future events, or otherwise, except as required under applicable law. All forward-looking statements contained in this release are expressly qualified in their entirety by this cautionary note.
1 U.S. Department of Health and Human Services. (2025, September 22). HHS provides more than
To view the source version of this press release, please visit https://www.newsfilecorp.com/release/268504
FAQ
What is the manufacturing agreement between Safe Supply (OTCQB:SSPLF) and MDBio?
How many ToxiShield test kits are included in each unit under the SSPLF manufacturing deal?
How much funding did HHS allocate for opioid response programs in 2025?
Where will Safe Supply's ToxiShield products be manufactured?
What substances can ToxiShield test kits detect?
